tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 133 are a BUY (76%), 40 are a HOLD (22.86%), 2 are a SELL (1.14%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 49.14% that have a potential upside of 42.3% achieved within 301 days.
Mara Goldstein’s has documented 327 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 12-May-2025.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$101
$-7.24 (-6.69%)
$101
5 years 10 months 15 days ago
(01-Nov-2019)
2/8 (25%)
$-7.53 (-6.94%)
171
Hold
$115
$6.76 (6.25%)
$102
5 years 10 months 15 days ago
(01-Nov-2019)
3/12 (25%)
$6.47 (5.96%)
382
Hold
$100
$-8.24 (-7.61%)
$128
6 years 28 days ago
(19-Aug-2019)
3/6 (50%)
$4.78 (5.02%)
159
Buy
$102
$-6.24 (-5.76%)
$105
6 years 4 months 13 days ago
(03-May-2019)
4/4 (100%)
$5.12 (5.28%)
207
Hold
$100
$-8.24 (-7.61%)
$100
6 years 5 months 11 days ago
(05-Apr-2019)
2/7 (28.57%)
$5.2 (5.49%)
282
Which stock is Mara Goldstein is most bullish on?
Which stock is Mara Goldstein is most reserved on?
What Year was the first public recommendation made by Mara Goldstein?
